Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Smurfit Westrock posts jump in annual earnings

(Sharecast News) - Cardboard packaging giant Smurfit Westrock reported a jump in annual earnings and said it expected to deliver adjusted core profit of about $1.25bn for the first quarter of the new fiscal year. The company announced a fourth-quarter net income of $146m and full-year net income of $319m, with a net income margin of 1.9% for the quarter and 1.5% for the year.

Fourth-quarter net sales surged to $7.5bn from $2.862bn a year ago and adjusted earnings before interest, taxes, depreciation and amortisation of $1.16bn. Annual combined adjusted EBITDA was $4.7bn, in line with guidance.

Net income for the three months from October to December rose to $146m from $50m in 2023.

Smurfit Westrock was formed after Smurfit Kappa, the largest paper packaging producer in Europe, completed its $11bn acquisition of US rival Westrock last July.

Chief executive Tony Smurfit said the $400m synergy programme was "on track and will be completed by the end of this year".

"Moreover, there are significant operational and commercial opportunities, at least equating to that synergy target," he added.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.